Journal of Virology, July 2000, p. 6592-6599, Vol. 74, No. 14
0022-538X/00/$04.00+0
Southeast Poultry Research Laboratory, USDA, Agricultural Research Service, Athens, Georgia 30605
Received 23 December 1999/Accepted 20 April 2000
| |
ABSTRACT |
|---|
|
|
|---|
Since the outbreak in humans of an H5N1 avian influenza virus in
Hong Kong in 1997, poultry entering the live-bird markets of Hong Kong
have been closely monitored for infection with avian influenza. In
March 1999, this monitoring system detected geese that were
serologically positive for H5N1 avian influenza virus, but the birds
were marketed before they could be sampled for virus. However, viral
isolates were obtained by swabbing the cages that housed the geese.
These samples, known collectively as A/Environment/Hong Kong/437/99
(A/Env/HK/437/99), contained four viral isolates, which were compared
to the 1997 H5N1 Hong Kong isolates. Analysis of A/Env/HK/437/99
viruses revealed that the four isolates are nearly identical
genetically and are most closely related to A/Goose/Guangdong/1/96. These isolates and the 1997 H5N1 Hong Kong viruses encode common hemagglutinin (H5) genes that have identical hemagglutinin cleavage sites. Thus, the pathogenicity of the A/Env/HK/437/99 viruses was
compared in chickens and in mice to evaluate the potential for disease
outbreaks in poultry and humans. The A/Env/HK/437/99 isolates were
highly pathogenic in chickens but caused a longer mean death time and
had altered cell tropism compared to A/Hong Kong/156/97 (A/HK/156/97).
Like A/HK/156/97, the A/Env/HK/437/99 viruses replicated in mice and
remained localized to the respiratory tract. However, the
A/Env/HK/437/99 isolates caused only mild pathological lesions in these
tissues and no clinical signs of disease or death. As a measure of the
immune response to these viruses, transforming growth factor
levels
were determined in the serum of infected mice and showed elevated
levels for the A/Env/HK/437/99 viruses compared to the A/HK/156/97
viruses. This study is the first to characterize the A/Env/HK/437/99
viruses in both avian and mammalian species, evaluating the H5 gene
from the 1997 Hong Kong H5N1 isolates in a different genetic
background. Our findings reveal that at least one of the avian
influenza virus genes encoded by the 1997 H5N1 Hong Kong viruses
continues to circulate in mainland China and that this gene is
important for pathogenesis in chickens but is not the sole determinant
of pathogenicity in mice. There is evidence that H9N2 viruses, which
have internal genes in common with the 1997 H5N1 Hong Kong isolates,
are still circulating in Hong Kong and China as well, providing a
heterogeneous gene pool for viral reassortment. The implications of
these findings for the potential for human disease are discussed.
| |
INTRODUCTION |
|---|
|
|
|---|
In March and April 1997, there were outbreaks of H5N1 avian influenza viruses on several poultry farms in the province of Hong Kong (8, 30). These viruses were highly pathogenic in chickens and resulted in high mortality of infected birds. During this same period, a 3-year-old boy was infected with an influenza virus that was approximately 99% identical by nucleotide sequence to the chicken H5N1 viruses isolated in the poultry outbreak (10, 11, 33, 35). The child subsequently died from complications of the viral infection. Later in the same year, 17 other confirmed cases of H5N1 avian influenza virus infection of humans were reported, 5 of which resulted in death (9, 12, 33, 44). These viruses were also nearly identical at the nucleotide level to viruses isolated from the avian influenza outbreak in chickens (3, 33, 35). Although avian influenza viruses have infected humans previously (13, 22, 39, 42), this was the first report of an avian influenza virus causing severe disease and death in a human host (11, 12, 35). The continuing occurrence of infection of humans with new subtypes of influenza virus led to fears of a deadly influenza pandemic. Fortunately, the H5N1 viruses were poorly spread by human-to-human contact, and each confirmed case was likely transmitted directly from bird to human, with the source being the live-bird markets of Hong Kong (30, 33). In an effort to control the human epidemic of H5N1 infection in Hong Kong, the poultry in Hong Kong were depopulated in December of 1997. No cases of humans infected with these H5N1 viruses were subsequently reported.
Since the outbreak, the 1997 H5N1 Hong Kong isolates from chickens and humans have been studied in both poultry and mice to determine the unique characteristics of these viruses that allowed them to cause lethal infections in both humans and chickens. For the viruses that have been evaluated for chickens by histopathology and immunohistochemistry, the endothelial cells of blood vessels throughout multiple visceral organs are the primary cell type where lesions and antigens are localized (33, 35). These findings have been reported for other highly pathogenic avian influenza (HPAI) viruses that cause peracute death in chickens (6, 20, 36, 41). Several of the 1997 H5N1 Hong Kong isolates have also been inoculated into mice to evaluate these animals as a model system for avian influenza virus pathogenesis in mammals (14, 16, 18, 21, 23, 26, 30). Independent researchers have found that these viruses are able to replicate and cause disease and high mortality in infected mice (14, 16, 18, 21, 23, 26, 30). Severe lesions of the upper and lower respiratory tract, including alveolar edema and alveolitis, were consistently observed in mice infected with the 1997 H5N1 Hong Kong viruses (14, 16, 18, 21, 23, 26, 30). However, there have been conflicting reports of systemic infection of mice by these viruses. Some researchers see no evidence of systemic infection (14), while in a few cases, others have isolated virus from other visceral organs and the brain (16, 18, 21, 23, 26, 30). These conflicting results may be related to the system used to propagate the viruses and to the number of times the viruses were passaged (14, 30).
Since the poultry of Hong Kong were depopulated at the end of 1997, the live-bird markets have been reestablished in Hong Kong, using the same sources of poultry as before the 1997 outbreak. These sources include some birds raised in Hong Kong, but most birds are imported from mainland China, primarily the province of Guangdong. A surveillance system has been set up to detect influenza virus in poultry that are used to stock the poultry markets in Hong Kong. In March 1999, this surveillance system detected antibodies to H5N1 influenza viruses in a shipment of geese from Guangdong province (L. Sims, personal communication). Although the birds had already been marketed when the results were obtained, the cages that housed the birds were sampled for virus isolation, and the viruses obtained are collectively referred to as A/Environment/Hong Kong/437/99 (A/Env/HK/437/99). Since these viruses were of the H5N1 subtype, their genetic relationship to the 1997 H5N1 Hong Kong viruses was determined. The pathogenicity of the A/Env/HK/437/99 isolates was also evaluated in both chickens and mice to ascertain the potential for future outbreaks of these viruses in both poultry and humans.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Viruses.
A/Env/HK/437-4/99, A/Env/HK/437-6/99,
A/Env/HK/437-8/99, A/Env/HK/437-10/99 (all received
from Les Sims at the Agriculture and Fisheries Department, Hong
Kong), and A/Human/Hong Kong/156/97 (A/HK/156/97) (received from Nancy
Cox at the Centers for Disease Control and Prevention, Atlanta, Ga.)
were passaged in specific-pathogen-free (SPF) 10-day-embryonated
chicken eggs. The allantoic fluid from infected eggs was harvested,
aliquoted, and stored at
70°C for use in all the experiments
described herein. The 50% embryo lethal dose (ELD50) was
determined in SPF 10-day-embryonated chicken eggs for each stock by the
method of Reed and Muench (25). These viruses were handled
in biosafety level 3 agriculture containment.
Molecular cloning, PCR amplification, and sequencing of viral isolates. The complete coding sequence of all eight gene segments was determined for all four A/Env/HK/437/99 isolates by methods previously described (33). Briefly, RNA was isolated from allantoic fluid of eggs inoculated with each isolate by using Trizol-LS reagent (Life Technologies, Grand Island, N.Y.). The purified RNA was then used in reverse transcriptase PCR (RT-PCR) to generate cDNA copies for cloning and direct sequencing. The RT step was carried out using Superscript II (Life Technologies) for 1 h at 45°C. Reagents for PCR were added directly to the RT reaction mixtures and amplified for 30 cycles at an annealing temperature of 53°C. The segments encoding the nonstructural (NS), nucleoprotein (NP), and matrix (M) genes were amplified using primers that were complementary to the conserved 5' 12 bp and 3' 13 bp of influenza virus gene segments. The primers used to amplify the hemagglutinin (HA) and neuraminidase (NA) gene segments were also complementary to these regions but were longer in order to provide greater specificity for these gene segments. The RT-PCR products were then electrophoresed on a 1.5% agarose gel and purified (Concert matrix extraction system; Life Technologies). The cDNAs were cloned, and colonies were screened by PCR using internal primers for the appropriate gene. Positive clones were grown overnight, and plasmids were extracted using the High Pure plasmid isolation kit (Boehringer Mannheim, Indianapolis, Ind.). cDNAs specific for the three polymerase gene segments (PA, PB1, and PB2) were also generated from viral RNA using RT-PCR. Each segment was amplified in three overlapping pieces, cut from an agarose gel, and purified as described above, except that the PCR annealing temperature was 56°C. The PCR products amplified from the polymerase gene segments were sequenced directly. All plasmids and PCR products were sequenced using a PRISM Ready Reaction Dye Deoxy Terminator cycle-sequencing kit (Perkin-Elmer) and run on a 373A automated sequencer (Perkin-Elmer).
Phylogenetic analysis. DNASTAR (Madison, Wis.) software was used to create sequence contigs and multiple-sequence alignments of the gene segments from the A/Env/HK/437/99 isolates. Maximum parsimony with 100 bootstrap replicates and a heuristic search method were used with PAUP 3.1 software (37) to generate phylogenetic trees. All phylogenetic trees are midpoint rooted and contain representative influenza virus isolates for each gene segment.
Chicken experiments.
To determine the pathogenicity of the
A/Env/HK/437/99 isolates, a modified U.S. Animal Health Association
chicken pathogenicity test was performed in 4-week-old SPF white
Plymouth Rock chickens (40). Briefly, birds were inoculated
via the intravenous route with 0.2 ml of a 10
1 dilution
of the bacterium-free virus stock. Based on back titer determination,
the doses were 106.6, 106.8, 106.8,
and 106.6 ELD50 of A/Env/HK/437-4/99,
A/Env/HK/437-6/99, A/Env/HK/437-8/99, and A/Env/HK/437-10/99,
respectively per chicken. Eight birds were inoculated per group for
pathogenicity testing, using death as the end point. Avian influenza
virus is considered to be highly pathogenic when at least 75% of the
birds die within 10 days of inoculation. Two additional birds were
inoculated per group (using the same route of inoculation and doses as
above), and these birds were euthanized with sodium pentobarbital (100 mg/kg of body weight) on day 2 postinoculation. Chickens that died
prior to day 2 postinoculation were necropsied on the day of death. The
lungs, bursa, kidneys, adrenal gland, thymus, thyroid, brain, liver,
heart, pancreas, intestine, spleen, and trachea were taken from these
birds and evaluated for gross lesions and by histopathology and
immunohistochemistry for influenza virus antigen. In a separate
experiment, eight 4-week-old SPF white Plymouth Rock chickens were
inoculated with 106 ELD50 of A/Env/HK/437-6/99
per chicken via the intranasal route. Two birds were euthanized on day
3 postinoculation, and tissues were taken and evaluated as described
above. The mean death time (MDT) was calculated by determining the sum
of the day of death postinoculation for the chickens and dividing by
the total number of chickens that died. Chicken experiments were
carried out in Horsfal-Bauer stainless steel isolation units ventilated
under negative pressure with HEPA-filtered air in biosafety level 3 agriculture facilities (2). Animal care was provided as
required by the Institutional Animal Care and Use Committee, based on
the Guide for the Care and Use of Agricultural Animals in Agricultural Research and Teaching. Food and water were provided ad libitum.
Mouse experiments. Seven-week-old male BALB/c mice (Simonsen Laboratories, Inc., Gilroy, Calif.) were anesthetized with ketamine-xylene (1.98 and 0.198 mg per mouse, respectively), and the inoculum was administered intranasally in 50 µl of phosphate-buffered saline (PBS). The data presented below were obtained from two experiments. In experiment 1, virus doses, based on back titers, were 105.5, 106.2, 106.2, and 105.8 ELD50 per mouse for A/Env/HK/437-4/99, A/Env/HK/437-6/99, A/Env/HK/437-8/99, and A/Env/HK/437-10/99, respectively. Eleven mice were inoculated per A/Env/HK/437/99 isolate. Eight mice of the 11 from each group were monitored daily for clinical signs of disease and death. Three mice of the 11 from each experimental group were euthanized on day 4 postinoculation with 50 µl of sodium pentobarbital (100 mg/kg of body weight) administered intraperitoneally. These mice were evaluated for gross lesions, and tissues were taken for virus isolation, histopathology, and immunohistochemistry. The trachea, lungs, and kidneys were removed, using aseptic techniques, for virus isolation. Briefly, tissues were weighed and homogenized in brain heart infusion broth to a 10% slurry. The ELD50 for each tissue was determined in SPF 10-day-embryonated chicken eggs, and the ELD50 per gram of tissue was calculated (14). The sinuses, bone marrow, brain, testes, thymus, kidneys, adrenal gland, lungs, vesicular gland, muscle, heart, liver, spleen, pancreas, intestine, and stomach were taken for evaluation by histopathology and immunohistochemistry for influenza virus antigen. The surviving mice were euthanized on day 14 postinoculation, and their lungs were evaluated by histopathology and immunohistochemistry.
In experiment 2, mice were set up in groups of eight and were anesthetized and inoculated with PBS only as a negative control or as described in experiment 1 above. As determined by back titer determination, mice were inoculated with 105.8, 105.6, or 105.6 ELD50 of A/Env/HK/437-6/99, A/Env/HK/437-10/99, or A/HK/156/97, respectively. The mice were weighed on days 0, 4, 6, 8, and 12 postinoculation. Blood was drawn from the tail vein at 1 and 4 days postinoculation. Sera from mice in the same group and same day postinoculation were pooled and used in experiments described below. Mice were monitored daily for clinical signs of disease and death until day 14 postinoculation, when the surviving mice were euthanized. The MDT was calculated for mice as described above. Mice were housed in standard polypropylene mouse cages and placed inside Horsfal-Bauer stainless steel isolation units that were ventilated with HEPA-filtered air. Experiments were carried out in the facilities and using the guidelines described above.Histopathology, ultrastructural pathology, and immunohistochemistry. Tissues were fixed in 10% neutral-buffered formalin solution, sectioned, and stained with hematoxylin and eosin. Duplicate sections were stained immunohistochemically to determine influenza virus antigen distribution in individual tissues. A monoclonal antibody against influenza A virus NP (P13C11), developed at Southeast Poultry Research Laboratory, was used as the primary antibody in a streptavidin-biotin-alkaline phosphatase complex immunohistochemical method as previously described (36).
Determination of TGF-
activity in mouse serum.
In mouse
experiment 2 described above, sera were pooled from mice within groups
on days 1 and 4 postinoculation. Transforming growth factor
(TGF-
) activity in the serum was determined by evaluating colony
formation of normal rat kidney (NRK) cells in the presence of epidermal
growth factor (EGF) in soft agar as previously described (28,
29). Briefly, 5% Noble agar (Difco, Detroit, Mich.) was diluted
to 0.5% in 10% calf serum-Dulbecco's modified Eagle's medium. This
solution was added to 24-well tissue culture plates as a base layer and
allowed to solidify. Serum samples, known amounts of TGF-
containing
1 ng of EGF, or 1 ng of EGF alone were added to liquid 0.5% agar and
2 × 103 NRK cells, and this mixture was added to the
plates containing the agar base layer. Cultures were incubated at
37°C under 5% CO2 for 7 days and then stained with 1%
neutral red in PBS. Colonies greater than 62 µm in diameter
(containing >8 to 10 cells) were counted. Samples were run in
triplicate. The amount of activated TGF-
in mouse serum was
estimated by plotting the standard amounts of TGF-
against the
number of colonies produced and then determining the linear best fit of
the data.
Nucleotide sequence accession numbers. Sequence data for the A/Env/HK/437/99 isolates have been submitted to GenBank. The accession numbers are as follows: A/Env/HK/437-4/99, AF216710 to AF216717; A/Env/HK/437-6/99, AF216718 to AF216725; A/Env/HK/437-8/99, AF216726 to AF216733; A/Env/HK/437-10/99, AF216734 to AF216741.
| |
RESULTS |
|---|
|
|
|---|
Phylogenetic analysis of A/Env/HK/437/99 isolates.
The
nucleotide sequences of all eight segments of the four A/Env/HK/437/99
isolates were determined, and phylogenetic trees were constructed using
available representative isolates for comparison. Relationships to the
H5N1 influenza viruses isolated in Hong Kong in 1997 were of particular
interest and are described below. The H5 HA1 phylogenetic tree shown in
Fig. 1A is composed of 35 isolates and
shows that avian influenza viruses isolated in North America grouped
together while those isolated in Europe or Asia grouped together
(27). As expected, the A/Env/HK/437/99 isolates grouped with
other Eurasian avian influenza viruses. The four A/Env/HK/437/99 viruses were nearly identical in nucleotide sequence (99.5 to 99.9%
identical) and were most closely related to the A/Goose/Guangdong/1/96 (A/GS/Guangdong/1/96) isolate, with 98.5 to 99% identity (Fig. 1A).
This analysis also showed that the H5 HA genes of the A/Env/HK/437/99 viruses were closely related to those of the H5N1 chicken and human
isolates from Hong Kong in 1997, indicating that the H5 HA genes
encoded by these viruses are from the same lineage (Fig. 1A)
(43). The sequence similarity among the A/Env/HK/437/99 isolates and A/HK/156/97, a representative isolate from Hong Kong in
1997, ranged from 98.2 to 98.5% nucleotide identity.
|
Pathogenicity of A/Env/HK/437/99 isolates in chickens and in mice. The A/Env/HK/437/99 isolates are closely related to A/GS/Guangdong/1/96. A/GS/Guangdong/1/96 caused an outbreak of disease in domestic geese that was associated with 40% morbidity in the field. This virus was experimentally inoculated into geese and chickens and reported to cause disease and death in these birds (38, 43). However, the details of these experiments are reported in Chinese or are not published. We evaluated the ability of the A/Env/HK/437/99 viruses to grow and cause disease in both chickens and mice. Our study includes detailed gross and histopathological evaluations of pathogenesis for both species and comparison of these findings to those from A/HK/156/97-infected chickens and mice.
To determine the pathogenicity of the A/Env/HK/437/99 isolates in chickens, the U.S. Animal Health Association chicken pathogenicity test was used (40). The birds infected with each of the four isolates exhibited clinical signs of disease that were consistent with an HPAI virus (1, 33, 36). In these experiments, 100% of the infected birds in each group died by day 5 postinoculation, with an average MDT of 3.4 days (Table 1). A virus is classified as highly pathogenic if 75% or more of the birds die within 10 days; thus, these viruses are highly pathogenic in chickens. Similar results were observed when chickens were inoculated intranasally, but the MDT (5.5 days) was longer (Table 1).
|
|
|
Analysis of tissues from chickens and mice inoculated with
A/Env/HK/437/99 by histopathology and immunohistochemistry.
Infection of chickens with the 1997 H5N1 Hong Kong viruses produced
severe systemic disease, with the most common lesions being severe
pulmonary edema, congestion, and hemorrhage; interstitial pneumonitis
with necrosis; necrosis of myocardial cells; and apoptosis of
lymphocytes in multiple primary and secondary lymphoid tissues (33, 35). Most frequently, avian influenza virus was
localized to the endothelial cells in different-sized blood vessels,
vascular sinuses, and endocardium. Influenza virus antigen was also
common in cardiac myocytes and in macrophages and heterophils of the lungs (33, 35). Similarly, the A/Env/HK/437/99 H5N1
influenza viruses produced systemic infections, lesions, and death in
chickens upon intravenous or intranasal inoculation. After intravenous inoculation, multiple foci of parenchymal cell necrosis in the pancreas, brain, and heart (Fig. 3a and
b) and lymphocyte depletion and apoptosis in the spleen, cloacal bursa,
thymus, and occasionally the cecal tonsil were the most consistent
lesions. Influenza virus NP was demonstrated most consistently in
necrotic parenchymal cells of the brain, pancreas, and heart (Fig. 3c
to e); sporadically in adrenal corticotrophic cells and kidney tubule
epithelium; and only rarely in vascular endothelial cells. After
intranasal inoculation, lymphocytic meningoencephalitis and myocarditis
were consistent lesions, and apoptosis and lymphocyte depletion were detected in primary and secondary lymphoid tissues. Influenza virus NP
was identified in the brain neurons and ependymal cells and in cardiac
myocytes (data not shown).
|
Comparison of levels of activated TGF-
in serum in
A/Env/HK/437/99- and A/HK/156/97-infected mice.
To evaluate
the host response to A/Env/HK/437/99 viruses, we examined the levels of
TGF-
activity in the sera of infected mice. TGF-
activity is
elevated in influenza virus-infected mice early in the course of
infection (14, 28). Studies in vitro show that the influenza
virus NA protein activates latent TGF-
, suggesting that the increase
in TGF-
activity in the serum of influenza virus-infected mice is
due to the in vivo activation of latent TGF-
by influenza virus NA
(28). Therefore, blood was obtained on days 1 and 4 postinoculation from mice inoculated with PBS only (negative control),
A/Env/HK/437-6/99, A/Env/HK/437-10/99, or A/HK/156/97 to evaluate
TGF-
activity in serum by using the NRK soft agar assay (28,
29). Control mice showed low levels of TGF-
activity that were
slightly above background (EGF alone) on both days 1 and 4 postinoculation (Fig. 4). Figure 4 shows that A/Env/HK/437-6/99- and A/Env/HK/437-10/99-infected mice had levels of TGF-
activity much higher than those in control
mice. As shown previously and in Fig. 4, A/HK/156/97-infected mice
exhibited low levels of TGF-
activity, similar to the levels
observed in control mice (14). These results showed that
there is an increase in the level of activated TGF-
in the sera of
mice infected with A/Env/HK/437-6/99 and A/Env/HK/437-10/99 over that
in the sera of mice infected with A/HK/156/97. These findings suggest
that the A/Env/HK/437/99 viruses, like many other avian influenza
viruses, elevate the levels of activated TGF-
in vivo (14,
28). In contrast, activated TGF-
levels in
A/HK/156/97-infected mouse serum are similar to those in the negative
control (14).
|
| |
DISCUSSION |
|---|
|
|
|---|
Genetic evaluation of the A/Env/HK/437/99 viruses clearly showed that these isolates have an HA gene in common with the 1997 H5N1 Hong Kong viruses and that all eight segments are closely related to A/GS/Guangdong/1/96. These findings show that these avian influenza virus genes have been in circulation for at least 3 years and that these viruses continue to circulate even after the poultry depopulation in Hong Kong. Other researchers have shown that H9N2 viruses (A/quail/HK/G1/97 and A/CK/HK/G9/97) isolated from Hong Kong in 1997 encode internal genes that are closely related to those of the 1997 H5N1 Hong Kong viruses (17). Since the depopulation of poultry in Hong Kong, H9N2 viruses have also been isolated from pigs, humans, and poultry in mainland China (references 19 and 24 and A. Hay, personal communication). It is clear from the data summarized here that the 1997 H5N1 Hong Kong viruses were derived as a result of reassortment of cocirculating viruses. Thus, the continued presence of genetically distinct avian influenza viruses in mainland China provides a varied pool of genes for generation of reassortant viruses. The presence of multiple genetically different viruses provides the potential for future outbreaks of human disease from avian influenza, especially with the cocirculation of viruses containing genes that contributed to the H5N1 outbreak in Hong Kong in 1997.
The pathogenicity of the HA gene associated with the 1997 H5N1 outbreak in Hong Kong was evaluated in chickens and mice infected with A/Env/HK/437/99 isolates. These studies provided the opportunity to examine the effects of the H5 gene on disease without the contribution of the other 1997 H5N1 Hong Kong virus genes. The 1997 H5N1 Hong Kong viruses caused severe disease in poultry (30, 33). Since HPAI viruses in poultry are generally characterized by H5 or H7 genes that encode multiple basic amino acids at the HA cleavage site (4, 5), it is not surprising that the A/Env/HK/437/99 isolates are also highly pathogenic in chickens. Although the HA gene made a major contribution to the virulence of A/HK/156/97 and the A/Env/HK/437/99 virus infection of chickens, other genes also had an effect on pathogenesis, since the main sites of infection and MDT values were different for these viruses (Fig. 3 and Table 1). These differences may be related to differences in the abilities of these viruses to infect different cell types or the rate of replication and/or dissemination of the viruses in the host.
Evaluation of A/Env/HK/437/99 isolates in mice revealed that these viruses, like A/HK/156/97, remained confined to the respiratory tract, where they replicated to detectable titers (Table 2) (14). However, A/Env/HK/437/99 did not cause clinical signs of disease in mice and histologically caused only mild pathological lesions in the upper respiratory tract. In contrast, A/HK/156/97 caused severe disease and pathological lesions in the upper and lower respiratory tract and resulted in death by 8 days postinoculation. These findings demonstrate that the HA gene of the 1997 H5N1 Hong Kong isolates is not sufficient alone to cause disease in a mammalian host and thus is not likely to be the major determinant of virulence in mammals as it is in poultry. Pathogenicity studies of A/quail/HK/G1/97 and A/CK/HK/G9/97 in chickens and mice confirm this data. These H9N2 isolates replicated in chickens, but the birds did not display any clinical signs of disease. However, these viruses caused severe disease in mice, killing three of eight and two of eight mice, respectively, without prior adaptation to the host (19).
The data from this study, as well as the evaluation of H9N2 Hong Kong
isolates (19) in mice, provide further evidence that the
ability of the 1997 H5N1 Hong Kong viruses to cause disease in mammals
is specified by multiple genes. The HA gene alone is not the sole
determinant of pathogenesis in mice, and the internal genes encoded by
A/quail/HK/G1/97 do not produce the same degree of virulence in these
animals as seen with A/HK/156/97. Thus, some combination of the
internal genes and the HA and/or NA of the 1997 H5N1 Hong Kong isolates
is likely responsible for the lethal phenotype. The NA gene has not
been evaluated in another genetic background; thus, its contribution to
pathogenesis is unknown. However, the NA gene of the 1997 H5N1 Hong
Kong viruses encodes a 19-amino-acid deletion, and others have shown
that NA stalk deletions can affect the ability of the NA to free
virions from red blood cells and to cause disease in mice (7,
15). These findings suggest that stalk length is important for NA
function and pathogenesis. Influenza virus NA is also known to activate latent TGF-
in vitro, by a direct or indirect mechanism (28, 29), and data presented here and by Dybing et al. (14)
show that latent TGF-
can also be activated in influenza
virus-infected mice as well. Unlike other influenza viruses, the 1997 H5N1 Hong Kong isolates tested do not produce elevated levels of
activated TGF-
in the sera of infected mice. Conversely, mice
infected with A/Env/HK/437/99 viruses have high levels of activated
TGF-
. Activated TGF-
levels in the sera of H9N2-infected mice
have not been determined. Unfortunately, the role of TGF-
in
influenza virus pathogenesis is not understood. However, TGF-
is
known to mediate both proinflammatory and immunosuppresive activities, depending on the levels produced. If activation of TGF-
by influenza virus infection is important for a proper immune response, it is
possible that the 1997 H5N1 Hong Kong viruses are more virulent, in
part, because they lack the ability to activate TGF-
to high levels.
The reduced ability to activate TGF-
may produce greater inflammation at the site of infection and thus cause more severe disease. Alternatively, the low levels of activated TGF-
in the sera
of A/HK/156/97-infected mice may allow the viruses to replicate and
spread unchecked in the respiratory tracts of the mice, causing more
severe disease. Studies are under way to explore these possibilities.
This study shows that the A/Env/HK/437/99 isolates are highly pathogenic in chickens but cause no clinical signs of disease in mice, suggesting that the H5 gene of the 1997 H5N1 viruses is important for virulence in poultry but is not the sole determinant of pathogenicity in mammals. When these data are reviewed along with those from other current literature, it becomes clear that the pathogenicity of the 1997 H5N1 Hong Kong viruses is multigenic. These results also show that the H5 gene of the 1997 H5N1 Hong Kong isolates is still circulating in HPAI viruses in China, even after poultry depopulation. This finding, in combination with the continued circulation of H9N2 viruses containing the internal genes of the 1997 H5N1 Hong Kong isolates, indicates that there is a pool of avian influenza virus genes that could cause disease in humans and poultry if reassortment occurs among the right group of viruses.
| |
ACKNOWLEDGMENTS |
|---|
We thank Joan Beck, Patsy Decker, Suzanne DeBlois, Liz Turpin, John Latimer, and Roger Brock for technical assistance. We thank Les Sims and Kitman Dyrting at the Agriculture and Fisheries Department in Hong Kong for providing the A/Env/HK/437/99 isolates and Robert Webster at St. Jude Children's Research Hospital, Memphis, Tenn., for transporting these isolates from Hong Kong. We thank Nancy Cox at the Centers for Disease Control and Prevention, Atlanta, Ga., for providing A/HK/156/97.
This work was supported by USDA/ARS Cris project number 6612-32000-022-93.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Southeast Poultry Research Laboratory, ARS/USDA, 934 College Station Rd., Athens, GA 30605. Phone: (706) 546-3479. Fax: (706) 546-3161. E-mail: dsuarez{at}seprl.usda.gov.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Alexander, D. J. 1982. Avian influenza. Recent developments. Vet. Bull. 52:341-359. |
| 2. | Barbeito, M. S., G. Abraham, M. Best, P. Cairns, P. Langevin, W. G. Sterritt, D. Barr, W. Meulepas, J. M. Sanchez-Vizcaino, M. Saraza, E. Requena, M. Collado, P. Mani, R. Breeze, H. Brunner, C. A. Mebus, R. L. Morgan, S. Rusk, L. M. Siegfried, and L. H. Thompson. 1995. Recommended biocontainment features for research and diagnostic facilities where animal pathogens are used. Rev. Sci. Tech. Off. Int. Epizoot. 14:873-887. |
| 3. | Bender, C., H. Hall, J. Huang, A. Klimov, N. Cox, A. Hay, V. Gregory, K. Cameron, W. Lim, and K. Subbarao. 1999. Characterization of the surface proteins of influenza A (H5N1) viruses isolated from humans in 1997-1998. Virology 254:115-123[CrossRef][Medline]. |
| 4. | Bosch, F. X., W. Garten, H. D. Klenk, and R. Rott. 1981. Cleavage of influenza virus hemagglutinins: primary structure of the connecting peptide between HA1 and HA2 determines proteolytic cleavability and pathogenicity of avian influenza virus. Virology 113:725-735[CrossRef][Medline]. |
| 5. | Bosch, F. X., M. Orlich, H. D. Klenk, and R. Rott. 1979. The structure of the hemagglutinin. A determinant for the pathogenicity of influenza viruses. Virology 95:197-207[CrossRef][Medline]. |
| 6. | Brown, C. C., H. J. Olander, and D. A. Senne. 1992. A pathogenesis study of highly pathogenic avian influenza virus H5N2 in chickens, using immunohistochemistry. J. Comp. Pathol. 107:341-348[CrossRef][Medline]. |
| 7. |
Castrucci, M. R., and Y. Kawaoka.
1993.
Biologic importance of neuraminidase stalk length in influenza A virus.
J. Virol.
67:759-764 |
| 8. |
Centers for Disease Control and Prevention.
1997.
Isolation of avian influenza A (H5N1) from humans Hong Kong, May-December, 1997.
Morbid. Mortal. Weekly Rep.
46:1204-1207[Medline].
|
| 9. | Centers for Disease Control and Prevention. 1998. Update: isolation of avian influenza A (H5N1) viruses from humans-Hong Kong, 1997-1998. Morbid. Mortal. Weekly Rep. 46:1245-1247[Medline]. |
| 10. | Claas, E. C. J., J. C. de Jong, R. van Beek, G. F. Rimmelzwaan, and A. D. M. E. Osterhaus. 1998. Human influenza virus A/Hong Kong/156/97 (H5N1) infection. Vaccine 16:977-978[CrossRef][Medline]. |
| 11. | Claas, E. C. J., A. D. M. E. Osterhaus, R. van Beek, J. C. De Jong, G. F. Rimmelzwaan, D. A. Senne, S. Krauss, K. F. Shortridge, and R. G. Webster. 1998. Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet 351:472-477[CrossRef][Medline]. |
| 12. | De Jong, J. C., E. C. J. Claas, and A. D. M. E. Osterhaus. 1997. A pandemic warning? Nature 389:554[Medline]. |
| 13. | DeLay, P. D., H. L. Casey, and H. S. Tubiash. 1967. Comparative study of fowl plaque virus and a virus isolated from man. Pub. Health Rep. 82:615-620[Medline]. |
| 14. |
Dybing, J. K.,
S. Schultz-Cherry,
D. E. Swayne,
D. L. Suarez, and M. L. Perdue.
2000.
Distinct pathogenesis of Hong Kong-origin H5N1 viruses in mice compared to that of other highly pathogenic H5 avian influenza viruses.
J. Virol.
74:1443-1450 |
| 15. | Els, M. C., G. M. Air, K. G. Murti, R. G. Webster, and W. G. Laver. 1985. An 18 amino acid deletion in an influenza neruaminidase. Virology 142:241-248[CrossRef][Medline]. |
| 16. |
Gao, P.,
S. Watanabe,
T. Ito,
H. Goto,
K. Wells,
M. McGregor,
A. J. Cooley, and Y. Kawaoka.
1999.
Biological heterogeneity, including systemic replication in mice, of H5N1 influenza A virus isolates from humans in Hong Kong.
J. Virol.
73:3184-3189 |
| 17. |
Guan, Y.,
K. F. Shortridge,
S. Krauss, and R. G. Webster.
1999.
Molecular characterization of H9N2 influenza viruses: were they the donors of the "internal" genes of H5N1 viruses in Hong Kong?
Proc. Natl. Acad. Sci. USA
96:9363-9367 |
| 18. | Gubareva, L. V., J. A. McCullers, R. C. Bethell, and R. G. Webster. 1998. Characterization of influenza A/Hong Kong/156/97 (H5N1) virus in a mouse model and protective effect of zanamivir on H5N1 infection in mice. J. Infect. Dis. 178:1592-1596[CrossRef][Medline]. |
| 19. | Guo, Y. J., S. Krauss, D. A. Senne, I. P. Mo, K. S. Lo, X. P. Xiong, M. Norwood, K. F. Shortridge, R. G. Webster, and Y. Guan. 2000. Characterization of the pathogenicity of members of the newly established H9N2 influenza virus lineages in Asia. Virology 267:279-288[CrossRef][Medline]. |
| 20. | Kobayashi, Y., T. Horimoto, Y. Kawaoka, D. J. Alexander, and C. Itakura. 1996. Pathological studies of chickens experimentally infected with two highly pathogenic avian influenza viruses. Avian Pathol. 25:285-304. |
| 21. |
Kodihalli, S.,
H. Goto,
D. L. Kobasa,
S. Krauss,
Y. Kawaoka, and R. G. Webster.
1999.
DNA vaccine encoding hemagglutinin provides protective immunity against H5N1 influenza virus infection in mice.
J. Virol.
73:2094-2098 |
| 22. | Kurtz, J., R. Manvell, and J. Banks. 1996. Avian influenza virus isolated from a woman with conjunctivitis. Lancet 348:901-902[CrossRef][Medline]. |
| 23. |
Lu, X.,
T. M. Tumpey,
T. Morken,
S. R. Zaki,
N. J. Cox, and J. M. Katz.
1999.
A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans.
J. Virol.
73:5903-5911 |
| 24. | Peiris, M., K. Y. Yuen, C. W. Leung, K. H. Chan, P. L. S. Ip, R. W. M. Lai, W. K. Orr, and K. F. Shortridge. 1999. Human infection with influenza H9N2. Lancet 354:916-917[CrossRef][Medline]. |
| 25. | Reed, L. J., and H. Muench. 1938. A simple method of estimating fifty per cent endpoints. Am. J. Hyg. 27:493-497. |
| 26. |
Riberdy, J. M.,
K. J. Flynn,
J. Stech,
R. G. Webster,
J. D. Altman, and P. C. Doherty.
1999.
Protection against a lethal avian influenza A virus in a mammalian system.
J. Virol.
73:1453-1459 |
| 27. | Rohm, C., T. Horimoto, Y. Kawaoka, J. Suss, and R. G. Webster. 1995. Do hemagglutinin genes of highly pathogenic avian influenza viruses constitute unique phylogenetic lineages? Virology 209:664-670[CrossRef][Medline]. |
| 28. |
Schultz-Cherry, S., and V. S. Hinshaw.
1996.
Influenza virus neuraminidase activates latent transforming growth factor- .
J. Virol.
70:8624-8629[Abstract].
|
| 29. |
Schultz-Cherry, S., and J. E. Murphy-Ullrich.
1993.
Thrombospondin causes activation of latent transforming growth factor- secreted by endothelial cells by a novel mechanism.
J. Cell Biol.
122:923-932 |
| 30. | Shortridge, K. R., N. N. Zhou, Y. Guan, P. Gao, T. Ito, Y. Kawaoka, S. Kodihalli, S. Krauss, D. Markwell, K. G. Murti, M. Norwood, D. Senne, L. Sims, A. Takada, and R. G. Webster. 1998. Characterization of avian H5N1 influenza viruses from poultry in Hong Kong. Virology 252:331-342[CrossRef][Medline]. |
| 31. |
Suarez, D. L.,
M. García,
J. Latimer,
D. Senne, and M. Perdue.
1999.
Phylogenetic analysis of H7 avian influenza viruses isolated from the live bird markets of the Northeast United States.
J. Virol.
73:3567-3573 |
| 32. | Suarez, D. L., and M. L. Perdue. 1998. Multiple alignment comparison of the non-structural genes of influenza A viruses. Virus Res. 54:59-69[CrossRef][Medline]. |
| 33. |
Suarez, D. L.,
M. L. Perdue,
N. Cox,
T. Rowe,
C. Bender,
J. Huang, and D. E. Swayne.
1998.
Comparisons of highly virulent H5N1 influenza A viruses isolated from humans and chickens from Hong Kong.
J. Virol.
72:6678-6688 |
| 34. | Suarez, D. L., and D. A. Senne. 1999. Sequence analysis of related low pathogenic and highly pathogenic H5N2 avian influenza isolates from the United States live bird markets and poultry farms from 1983-1989. Avian Dis. 44:356-364. |
| 35. |
Subbarao, K.,
A. Klimov,
J. Katz,
H. Regnery,
W. Lim,
H. Hall,
M. Perdue,
D. Swayne,
C. Bender,
J. Huang,
M. Hemphill,
T. Rowe,
M. Shaw,
X. Xu,
K. Fukuda, and N. Cox.
1998.
Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness.
Science
279:393-396 |
| 36. | Swayne, D. E. 1997. Pathobiology of H5N2 Mexican avian influenza virus infections of chickens. Vet. Pathol. 34:557-567[Abstract]. |
| 37. | Swofford, D. 1989. PAUP: phylogenetic analysis using parsimony, version 3 ed. Illinois Natural History Survey, Champaign. |
| 38. | Tang, X., G. Tian, C. Zhao, J. Zhou, and K. Y. 1998. Isolation and characterization of prevalent strains of avian influenza viruses in China. Chin. J. Anim. Poult. Infect. Dis. 20:1-5. (In Chinese.) |
| 39. |
Taylor, H. R., and A. J. Turner.
1977.
A case report of fowl plaque keratoconjunctivitis.
Br. J. Ophthalmol.
61:86-88 |
| 40. | U.S. Animal Health Association. 1994. Report of the committee on transmissible diseases of poultry and other avian species. Criteria for determining that an AI virus isolation causing an outbreak must be considered for eradication, p. 522. In Proceedings of the 98th Annual Meeting of the U.S. Animal Health Association. U.S. Animal Health Association, Grand Rapids, Mich. |
| 41. |
Van Campen, H.,
B. C. Easterday, and V. S. Hinshaw.
1989.
Virulent avian influenza A viruses: Their effect on avian lymphocytes and macrophages in vivo and in vitro.
J. Gen. Virol.
70:2887-2895 |
| 42. | Webster, R. G., J. Geraci, G. Petursson, and K. Skirnisson. 1981. Conjunctivitis in human beings caused by influenza A virus of seals. N. Engl. J. Med. 304:911[Medline]. |
| 43. | Xu, S., K. Subbarao, N. J. Cox, and Y. Guo. 1999. Genetic characterization of the pathogenic influenza A/Goose/Guangdong/1/96 (H5N1) virus: similarity of its hemagglutinin gene to those of H5N1 viruses from the 1997 outbreaks in Hong Kong. Virology 261:15-19[CrossRef][Medline]. |
| 44. | Yuen, K. Y., P. K. S. Chan, M. Peiris, D. N. C. Tsang, T. L. Que, K. F. Shortridge, P. T. Cheung, W. K. To, E. T. F. Ho, R. Sung, A. F. B. Cheng, and Members of the H5N1 Study Group. 1998. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet 351:467-471[CrossRef][Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||